Skip to main content

Abstract

The cancer experience exists as a continuum, beginning with diagnosis and continuing through the phases of treatment toward long-term survival [1]. The term “cancer survivor” is used to describe any person diagnosed with cancer, including those currently fighting the disease or those who have become cancer-free. Treatments aim to remove all traces of the cancer from the body, prolong survival, and provide the highest possible quality of life. However, many survivors experience adverse long-term effects from the treatment, including physical and/or psychological symptoms. Supportive cancer care is designed to understand and treat these cancer-associated and cancer-induced symptoms to provide lasting physical and emotional well-being for survivors and their families at all stages of the illness [2]. Education, management, and continuous support are essential to reducing these adverse side effects of cancer and its treatments in order to enhance the quality of life for cancer patients and caregivers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313(4):270–3.

    Article  CAS  PubMed  Google Scholar 

  2. Cherny NI, Catane R, Kosmidis P. ESMO Taskforce on Supportive and Palliative Care. ESMO takes a stand on supportive and palliative care. Ann Oncol. 2003;14(9):1335–7.

    Article  CAS  PubMed  Google Scholar 

  3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. Available at http://globocan.iarc.fr.

  4. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–45.

    Article  CAS  PubMed  Google Scholar 

  5. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.

    Article  PubMed  Google Scholar 

  6. Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5 Suppl 1:3–29.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290–314.

    Article  PubMed  Google Scholar 

  8. Temel JS, Jackson VA, Billings JA, Dahlin C, Block SD, Buss MK, et al. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients. J Clin Oncol. 2007;25(17):2377–82.

    Article  PubMed  Google Scholar 

  9. Greer JA, Pirl WF, Jackson VA, Muzikansky A, Lennes IT, Heist RS, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012;30(4):394–400.

    Article  PubMed  Google Scholar 

  10. Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol. 2010;6(12):657–66.

    Article  PubMed  Google Scholar 

  11. American Cancer Society. Cancer treatment and survivorship facts & figures 2014–2015. Atlanta: American Cancer Society; 2014.

    Google Scholar 

  12. Fraumeni JF, Curtis RE, Edwards BK, Tucker MA. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. Bethesda: NIH Publ. No. 05-5302; 2006.

    Google Scholar 

  13. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist. 2007;12(1):20–37.

    Article  PubMed  Google Scholar 

  14. Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006.

    Google Scholar 

  15. Fashoyin-Aje LA, Martinez KA, Dy SM. New patient-centered care standards from the commission on cancer: opportunities and challenges. J Support Oncol. 2012;10(3):107–11.

    Article  PubMed  Google Scholar 

  16. Digiulo S. ASCO releases first guidelines on survivorship care. Oncol Times. 2014;25:9–10.

    Article  Google Scholar 

  17. Kvale E, Urba SG. NCCN guidelines for survivorship expanded to address two common conditions. J Natl Compr Canc Netw. 2014;12(5 Suppl):825–7.

    PubMed  Google Scholar 

  18. NHLBI Fact Book, Fiscal Year 2012. Available at: http://www.nhlbi.nih.gov/files/docs/factbook/FactBook2012.pdf. Accessed 31 Aug 2014.

  19. Guy Jr GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749–57.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wagner L, Lacey MD. The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs. 2004;8(3):279–87.

    Article  PubMed  Google Scholar 

  21. Lowery WJ, Lowery AW, Barnett JC, Lopez-Acevedo M, Lee PS, Secord AA, et al. Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2013;130(3):426–30.

    Article  PubMed  Google Scholar 

  22. Norton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE. Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients. Crit Care Med. 2007;35(6):1530–5.

    Article  PubMed  Google Scholar 

  23. Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care; Smedley BD, Stith AY, Nelson AR, editors. Washington (DC): National Academies Press (US); 2003.

    Google Scholar 

  24. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.

    Article  PubMed  Google Scholar 

  25. Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, et al. Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2108–17.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Alberts .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Alberts, D., Lluria-Prevatt, M., Kha, S., Weihs, K. (2016). Introduction. In: Alberts, D., Lluria-Prevatt, M., Kha, S., Weihs, K. (eds) Supportive Cancer Care. Springer, Cham. https://doi.org/10.1007/978-3-319-24814-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-24814-1_1

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-24812-7

  • Online ISBN: 978-3-319-24814-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics